Federal Supply Schedule V797D30223
Award Date 10/1/13
Last Date to Order 4/15/17
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Other Statutory Authority
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed Similar IDVs
- The Indefinite Delivery Contract (IDC) SPE2DR25D3026, awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, is a $9.99 billion single-award contract to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract encompasses a 30-month base period with three 30-month option periods, running through December 2036. As the prime vendor, Amerisourcebergen will be...
- The Department of Veterans Affairs National Acquisition Center awarded a single-award Indefinite Delivery Contract to Exelan Pharmaceuticals Inc. effective June 20, 2022, with a ceiling value of $15.58 million and ultimate completion date of June 19, 2025. The contract establishes a framework for the provision of ibuprofen tablets and related pharmaceutical repackaging services to support the VA's Pharmaceutical Repackaging Program, which consolidates bulk pharmaceutical products into...
- The Department of Veterans Affairs Veterans Integrated Service Network 6 (VISN 6) awarded a single-award Indefinite Delivery Contract valued at $5,990,475.20 to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc., effective January 1, 2025, through December 31, 2028. This base Indefinite Delivery, Indefinite Quantity (IDIQ) contract procures F-18 Pylarify (piflufolastat F-18), a radioactive diagnostic radiopharmaceutical agent used in positron emission tomography (PET)...
- This is a Federal Supply Schedule contract awarded by the U.S. Department of Veterans Affairs (VA) to Ibsa Pharma Inc., a foreign-owned for-profit organization. The contract, classified under FSS-61-IB, is for the provision of pharmaceuticals, drugs, and hematology-related products. The contract has a ceiling value of $1,020,000.00 and a period of performance from May 15, 2019, to January 31, 2026. As a Federal Supply Schedule contract, it is a multiple-award vehicle that allows other government...
- Grifols USA LLC holds a $1.381 billion Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs FSS-61-IB category, awarded by Veterans Integrated Service Network 12 (VISN 12), a civilian component of the Department of Veterans Affairs. This multiple-award indefinite delivery vehicle was established on May 1, 2022, with an ultimate completion date of April 30, 2027. The contract operates on a firm fixed-price basis with no set-aside designations, reflecting Grifols' status as a...
- Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., was awarded a multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) by the Department of Veterans Affairs through Veterans Integrated Service Network 12, with an award date of September 1, 2024 and an ultimate completion date of August 31, 2029. This contract has a ceiling value of $6.9 billion and represents a significant procurement vehicle for specialty pharmaceutical products to...
- Servier Pharmaceuticals LLC was awarded a multiple-award Federal Supply Schedule contract for drugs, pharmaceuticals, and hematology-related products under General Services Administration Master Schedule FSS-61-IB on September 15, 2020, with an ultimate completion date of March 14, 2026. The contract carries a ceiling value of $19.3 million and was funded through the Department of Veterans Affairs Veterans Integrated Service Network 12. No set-aside designation was applied to this award, and the...
- This Federal Supply Schedule contract, awarded September 15, 2018, and completed September 14, 2026, provides pharmaceutical and radiopharmaceutical products through a multiple-award vehicle with a $3.5M ceiling value. Curium US LLC, a foreign-owned manufacturer of radiopharmaceuticals and nuclear medicine products headquartered in Maryland Heights, Missouri, serves as the primary contractor supplying specialized medical imaging and diagnostic solutions to Veterans Integrated Service Network 12....
- 3M Company was awarded a single-award Indefinite Delivery Contract (IDC) by the Defense Logistics Agency's Medical Supply Chain division on August 1, 2023, with a ceiling value of $46.7 million and ultimate completion date of July 31, 2033. The contract, designated SPE2D0 and issued without small business set-aside restrictions, establishes 3M as a qualified supplier for medical supplies and equipment supporting Department of Defense healthcare infrastructure and operations. As a large,...
- The Department of Veterans Affairs Veterans Health Administration awarded a multiple-award Federal Supply Schedule contract to Biocon Biologics Inc., a foreign-owned, for-profit manufacturer of goods. The contract provides an interim agreement under FSS Schedule 65 I B for drugs, pharmaceuticals, and hematology-related products. The potential value of the contract is $25 million. Delivery orders may be placed under the contract through February 2029. The contract facilitates procurement of...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D30223Federal Supply Schedule
- Blanket Purchase Agreements
- 1Federal Contract Awards
65IB DRUGS, PHARMACEUTICALS, AND HEMATOLOGY RELATED PRODUCTS
Posted 9/19/13
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00032 | Other Administrative Action | $0 | 4/11/17 | |
| P00030 | Other Administrative Action | $0 | 10/25/16 | |
| P00029 | Other Administrative Action | $0 | 7/14/16 | |
| P00028 | Supplemental Agreement for work within scope | $0 | 1/7/16 | |
| P00027 | Supplemental Agreement for work within scope | $0 | 12/29/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order V797D30223-VA24814J3670 | Covis Pharmaceuticals, Inc. | $16.5k | 6/5/14 | 6/13/14 | 6/5/14 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
New contract award ICO Amphastar Pharmaceuticals | 65IB | Department of Veterans Affairs National Acquisition Center | Award Notice 1/1 | 2/10/11, 3:09 PM |